BRCA2 and posterior cortical atrophy: Approximately 12% of patients with metastatic prostate cancer (PCa) harbor a PGV in genes involved in homologous DNA repair or mismatch repair such as BRCA1, BRCA2, ATM, MSH2, or other DNA damage repair (DDR) genes [1].